相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting Metabolic Deregulation Landscapes in Breast Cancer Subtypes
Erandi A. Serrano-Carbajal et al.
FRONTIERS IN ONCOLOGY (2020)
Lactate preconditioning promotes a HIF-1α-mediated metabolic shift from OXPHOS to glycolysis in normal human diploid fibroblasts
Alexandra M. Kozlov et al.
SCIENTIFIC REPORTS (2020)
Glutamine reliance in cell metabolism
Hee Chan Yoo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Targeting phosphatidylinositol 3 kinase-β and -δ for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma
Neeraj Jain et al.
BLOOD ADVANCES (2020)
The Metabolomic Profile of Lymphoma Subtypes: A Pilot Study
Luigi Barberini et al.
MOLECULES (2019)
The IL411 Enzyme: A New Player in the Immunosuppressive Tumor Microenvironment
Valerie Molinier-Frenkel et al.
CELLS (2019)
Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment
Yang Liu et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment
Martina Rudelius et al.
HAEMATOLOGICA (2018)
IL-4-Induced Gene 1: A Negative Immune Checkpoint Controlling B Cell Differentiation and Activation
Lloyd Bod et al.
JOURNAL OF IMMUNOLOGY (2018)
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment
Martina Rudelius et al.
HAEMATOLOGICA (2018)
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocyticleukaemia treated with ibrutinib from 3 clinical trials
Jeffrey Jones et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Role of Bruton's tyrosine kinase in B cells and malignancies
Simar Pal Singh et al.
MOLECULAR CANCER (2018)
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Jennifer R. Molina et al.
NATURE MEDICINE (2018)
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
R. Schmitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Are BTK and PLCG2 mutations necessary and sufficient for ibrutinib resistance in chronic lymphocytic leukemia?
Benjamin L. Lampson et al.
EXPERT REVIEW OF HEMATOLOGY (2018)
Active mitochondria support osteogenic differentiation by stimulating β-catenin acetylation
Brianna H. Shares et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Rewiring urea cycle metabolism in cancer to support anabolism
Rom Keshet et al.
NATURE REVIEWS CANCER (2018)
Metabolic interaction between urea cycle and citric acid cycle shunt: A guided approach
Rossana Pesi et al.
BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION (2018)
Comprehensive Metaboproteomics of Burkitt's and Diffuse Large B-Cell Lymphoma Cell Lines and Primary Tumor Tissues Reveals Distinct Differences in Pyruvate Content and Metabolism
Philipp Schwarzfischer et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Hsu-Ping Kuo et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia
Inhye E. Ahn et al.
BLOOD (2017)
STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2016)
Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma
Qing Ye et al.
ONCOTARGET (2016)
p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function
Zijun Y. Xu-Monette et al.
AGING-US (2016)
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Elizabeth C. Townsend et al.
CANCER CELL (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Recombinant expression, purification and crystallographic studies of the mature form of human mitochondrial aspartate aminotransferase
Xiuping Jiang et al.
BIOSCIENCE TRENDS (2016)
Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells
Bradley Smith et al.
CELL REPORTS (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
Mechanisms of ibrutinib resistance in chronic lymphocytic leukaemia and non-Hodgkin lymphoma
Shuang Q. Zhang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis
Kivanc Birsoy et al.
CELL (2015)
SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth
Hui Yang et al.
EMBO JOURNAL (2015)
Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma
Saverio Tardito et al.
NATURE CELL BIOLOGY (2015)
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wyndham H. Wilson et al.
NATURE MEDICINE (2015)
Structure of human carbamoyl phosphate synthetase: deciphering the on/off switch of human ureagenesis
Sergio de Cima et al.
SCIENTIFIC REPORTS (2015)
A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia
David L. Tucker et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2015)
Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications
Georg Lenz
CANCERS (2015)
Diffuse large B-cell lymphoma-treatment approaches in the molecular era
Mark Roschewski et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Targeting early B-cell receptor signaling induces apoptosis in leukemic mantle cell lymphoma
Mohand-Akli Boukhiar et al.
EXPERIMENTAL HEMATOLGY & ONCOLOGY (2013)
A Mitochondrial Power Play in Lymphoma
Ralph J. DeBerardinis
CANCER CELL (2012)
Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma
Pilar Caro et al.
CANCER CELL (2012)
My Treatment Approach to Patients With Diffuse Large B-Cell Lymphoma
James O. Armitage
MAYO CLINIC PROCEEDINGS (2012)
Plakophilin3 Loss Leads to an Increase in PRL3 Levels Promoting K8 Dephosphorylation, Which Is Required for Transformation and Metastasis
Nileema Khapare et al.
PLOS ONE (2012)
Diffuse Large B-Cell Lymphoma: Current Strategies and Future Directions
Jennifer L. Cultrera et al.
CANCER CONTROL (2012)
Argininosuccinate Lyase Deficiency-Argininosuccinic Aciduria and Beyond
Ayelet Erez et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
Dynamic metabolomic data analysis: a tutorial review
A. K. Smilde et al.
METABOLOMICS (2010)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma
Linfeng Chen et al.
BLOOD (2008)
Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation
Marie-Laure Boulland et al.
BLOOD (2007)
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
S Monti et al.
BLOOD (2005)
Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle
A Husson et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
分享论文
